Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Cash from Operations (2016 - 2025)

Historic Cash from Operations for HealthLynked (HLYK) over the last 10 years, with Q3 2025 value amounting to -$444291.0.

  • HealthLynked's Cash from Operations rose 5715.49% to -$444291.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year increase of 4831.15%. This contributed to the annual value of -$3.5 million for FY2024, which is 1570.0% up from last year.
  • Per HealthLynked's latest filing, its Cash from Operations stood at -$444291.0 for Q3 2025, which was up 5715.49% from -$417536.0 recorded in Q2 2025.
  • In the past 5 years, HealthLynked's Cash from Operations registered a high of $634168.0 during Q3 2021, and its lowest value of -$2.4 million during Q4 2021.
  • Its 5-year average for Cash from Operations is -$911350.7, with a median of -$1.0 million in 2024.
  • Its Cash from Operations has fluctuated over the past 5 years, first skyrocketed by 1201597.14% in 2021, then crashed by 29624.01% in 2022.
  • Over the past 5 years, HealthLynked's Cash from Operations (Quarter) stood at -$2.4 million in 2021, then skyrocketed by 74.9% to -$600376.0 in 2022, then tumbled by 98.59% to -$1.2 million in 2023, then surged by 37.63% to -$743602.0 in 2024, then surged by 40.25% to -$444291.0 in 2025.
  • Its Cash from Operations stands at -$444291.0 for Q3 2025, versus -$417536.0 for Q2 2025 and -$432553.0 for Q1 2025.